A detailed history of Virtus ETF Advisers LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,465 shares of VERA stock, worth $119,084. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,465
Previous 2,420 1.86%
Holding current value
$119,084
Previous $87,000 24.14%
% of portfolio
0.05%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$34.09 - $46.71 $1,534 - $2,101
45 Added 1.86%
2,465 $108,000
Q2 2024

Aug 14, 2024

SELL
$33.72 - $48.82 $116,873 - $169,210
-3,466 Reduced 58.89%
2,420 $87,000
Q1 2024

May 15, 2024

SELL
$14.91 - $49.14 $6,008 - $19,803
-403 Reduced 6.41%
5,886 $253,000
Q4 2023

Feb 15, 2024

BUY
$9.29 - $16.0 $58,424 - $100,624
6,289 New
6,289 $96,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.31B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.